126 related articles for article (PubMed ID: 11878118)
21. Intravenous iron sucrose in two pregnant women with inflammatory bowel disease and severe iron deficiency anemia.
Krafft A; Breymann C; Huch R; Huch A
Acta Obstet Gynecol Scand; 2000 Aug; 79(8):720-2. PubMed ID: 10949245
[No Abstract] [Full Text] [Related]
22. Fatal anaphylactic reaction to iron sucrose in pregnancy.
Mishra A; Dave N; Viradiya K
Indian J Pharmacol; 2013; 45(1):93-4. PubMed ID: 23543624
[TBL] [Abstract][Full Text] [Related]
23. Iron sucrose or ferric gluconate?
Duffy CI
Am J Kidney Dis; 2001 Dec; 38(6):1442. PubMed ID: 11728988
[No Abstract] [Full Text] [Related]
24. Intravenous iron sucrose versus oral iron in treatment of iron deficiency anemia in pregnancy: a randomized clinical trial.
Kochhar PK; Kaundal A; Ghosh P
J Obstet Gynaecol Res; 2013 Feb; 39(2):504-10. PubMed ID: 22925176
[TBL] [Abstract][Full Text] [Related]
25. Treatment of iron deficiency and iron deficiency anemia with intravenous ferric carboxymaltose in pregnancy.
Froessler B; Gajic T; Dekker G; Hodyl NA
Arch Gynecol Obstet; 2018 Jul; 298(1):75-82. PubMed ID: 29740690
[TBL] [Abstract][Full Text] [Related]
26. Ferric carboxymaltose vs. oral iron in the treatment of pregnant women with iron deficiency anemia: an international, open-label, randomized controlled trial (FER-ASAP).
Breymann C; Milman N; Mezzacasa A; Bernard R; Dudenhausen J;
J Perinat Med; 2017 May; 45(4):443-453. PubMed ID: 27278921
[TBL] [Abstract][Full Text] [Related]
27. [Current recommendations for the treatment of iron deficiency anemia].
Schaefer RM; Huch R; Krafft A;
Rev Med Suisse; 2007 Apr; 3(105):874-80. PubMed ID: 17514929
[TBL] [Abstract][Full Text] [Related]
28. [Iron metabolism in women with anemia and eclampsia (Part I)].
Orlov IuP; Lukach VN; Govorova NV
Anesteziol Reanimatol; 2014; 59(6):67-72. PubMed ID: 25831707
[TBL] [Abstract][Full Text] [Related]
29. Efficacy and safety of oral iron(III) polymaltose complex versus ferrous sulfate in pregnant women with iron-deficiency anemia: a multicenter, randomized, controlled study.
Ortiz R; Toblli JE; Romero JD; Monterrosa B; Frer C; Macagno E; Breymann C
J Matern Fetal Neonatal Med; 2011 Nov; 24(11):1347-52. PubMed ID: 21859366
[TBL] [Abstract][Full Text] [Related]
30. Comparison of adverse event profile of intravenous iron sucrose and iron sucrose similar in postpartum and gynecologic operative patients.
Lee ES; Park BR; Kim JS; Choi GY; Lee JJ; Lee IS
Curr Med Res Opin; 2013 Feb; 29(2):141-7. PubMed ID: 23252876
[TBL] [Abstract][Full Text] [Related]
31. Fibroblast growth factor 23-related osteomalacia caused by the prolonged administration of saccharated ferric oxide.
Yamamoto S; Okada Y; Mori H; Fukumoto S; Tanaka Y
Intern Med; 2012; 51(17):2375-8. PubMed ID: 22975552
[TBL] [Abstract][Full Text] [Related]
32. Intravenous iron treatment in pregnancy: comparison of high-dose ferric carboxymaltose vs. iron sucrose.
Christoph P; Schuller C; Studer H; Irion O; De Tejada BM; Surbek D
J Perinat Med; 2012 May; 40(5):469-74. PubMed ID: 22945271
[TBL] [Abstract][Full Text] [Related]
33. Fetal bradycardia following maternal administration of low-molecular-weight intravenous iron.
Woodward T; Kay T; Rucklidge M
Int J Obstet Anesth; 2015 May; 24(2):196-7. PubMed ID: 25794420
[No Abstract] [Full Text] [Related]
34. Approaches for optimising intravenous iron dosing in pregnancy: a retrospective cohort study.
Grzeskowiak LE; Qassim A; Jeffries B; Grivell RM
Intern Med J; 2017 Jul; 47(7):747-753. PubMed ID: 28444883
[TBL] [Abstract][Full Text] [Related]
35. Diagnosis and treatment of iron-deficiency anaemia in pregnancy and postpartum.
Breymann C; Honegger C; Hösli I; Surbek D
Arch Gynecol Obstet; 2017 Dec; 296(6):1229-1234. PubMed ID: 28940095
[TBL] [Abstract][Full Text] [Related]
36. Safety and efficacy of lactoferrin versus ferrous sulphate in curing iron deficiency and iron deficiency anaemia in hereditary thrombophilia pregnant women: an interventional study.
Paesano R; Pacifici E; Benedetti S; Berlutti F; Frioni A; Polimeni A; Valenti P
Biometals; 2014 Oct; 27(5):999-1006. PubMed ID: 24590680
[TBL] [Abstract][Full Text] [Related]
37. Parenteral iron therapy options.
Silverstein SB; Rodgers GM
Am J Hematol; 2004 May; 76(1):74-8. PubMed ID: 15114602
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and safety of intravenously administered iron sucrose with and without adjuvant recombinant human erythropoietin for the treatment of resistant iron-deficiency anemia during pregnancy.
Breymann C; Visca E; Huch R; Huch A
Am J Obstet Gynecol; 2001 Mar; 184(4):662-7. PubMed ID: 11262469
[TBL] [Abstract][Full Text] [Related]
39. Hepatocellular damage following therapeutic intravenous iron sucrose infusion in a child.
Wood DM; Thomson AH; Lawes M; Jones AL; Dargan PI
Ther Drug Monit; 2005 Aug; 27(4):405-8. PubMed ID: 16044093
[TBL] [Abstract][Full Text] [Related]
40. Treatment of anaemia in inflammatory bowel disease with iron sucrose.
Bodemar G; Kechagias S; Almer S; Danielson BG
Scand J Gastroenterol; 2004 May; 39(5):454-8. PubMed ID: 15180183
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
